Felipe Valença-Pereira

University of Colorado Anschutz Medical Campus

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation”.

Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation

Nature Communications(2020)10.1038/s41467-020-16991-2

N/A

0DataRank · unranked

146 citations

Karen A. Fortner, Paula Iruzubieta, Teresa C. Delgado, Emily Giddings, Youdinghuan Chen +21 more

Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance

Nature Communications(2021)10.1038/s41467-021-23071-6

N/A

0DataRank · unranked

202 citations

Devin Champagne, Meng-Han Wu, Joshua M. Laffin, Tina M. Thornton, Felipe Valença-Pereira +20 more

Deleting the mitochondrial respiration negative regulator MCJ enhances the efficacy of CD8+ T cell adoptive therapies in pre-clinical studies

Nature Communications(2024)10.1038/s41467-024-48653-y

N/A

0DataRank · unranked

18 citations

Felipe Valença-Pereira, Francesca Cendali, Emily Giddings, Catherine Pham‐Danis, Michael Yarnell +9 more